factor-targeting ADC
Exelixis Abandons Tissue Factor-Targeting ADC Due to Competition from Tivdak
Exelixis, tissue factor-targeting ADC, Tivdak, biotech, pharmaceuticals, drug development
Actionable Insights Powered by AI
Exelixis, tissue factor-targeting ADC, Tivdak, biotech, pharmaceuticals, drug development